Ueda, Yutaka <br/><br/>
In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Aug 2003 
 - 2471-80 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.47.8.2471-2480.2003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abscess--drug therapy<br/>Acetamides--pharmacology<br/>Ampicillin Resistance<br/>Animals<br/>Anti-Bacterial Agents--pharmacology<br/>Bacterial Proteins<br/>Carbapenems--pharmacology<br/>Carrier Proteins<br/>Dipeptidases--metabolism<br/>Drug Resistance, Multiple, Bacterial<br/>Gram-Negative Bacteria--drug effects<br/>Gram-Positive Bacteria--drug effects<br/>Gram-Positive Bacterial Infections--microbiology<br/>Hexosyltransferases--metabolism<br/>Kidney--enzymology<br/>Linezolid<br/>Male<br/>Mice<br/>Mice, Inbred ICR<br/>Microbial Sensitivity Tests<br/>Multienzyme Complexes--metabolism<br/>Muramoylpentapeptide Carboxypeptidase<br/>Oxazolidinones--pharmacology<br/>Penicillin-Binding Proteins<br/>Peptidyl Transferases--metabolism<br/>Vancomycin--pharmacology<br/>Vancomycin Resistance<br/>beta-Lactamases--metabolism